Venstramedical Pty Ltd

VenstraMedical is an Australian medtech company developing the smallest and most powerful percutaneous cardiac assist device for patients with cardiogenic shock and those undergoing high risk coronary interventions. The low-profile pump delivers up to 7 litres per minute of support and collapses into a 9Fr catheter for insertion across the aortic valve. Backed by 7 issued patents, the company is preparing for Series B to fund clinical trials, with strong strategic and institutional interest.